SUSPENSION
GAMPOD 50 DS
Cefpodoxime 50 mg (with wfi)
Remarkable Speed
- Greater in vitro activity against S.pneumoniae than cefaclor, cefuroxime, cefprozile or cefixime
Broad spectrum of antibacterial activity
- Extremely low mic values against common respiratory pathogens
- Empirical treatment for a wide range of community acquired infections
High Discipline
- Infants 2 months – children 12 years: 5 mg/kg every 12 hours
Favorable pharmacokinetic profile
- Excellent bacteriological & clinical efficacy in pediatric patients
Reviews
There are no reviews yet.